instead read "The number of peripheral blood lymphocytes and granulocytes did not change in the aVAP2-administered mice: WBCs: 2.11 (1.36-2.44)×10 9 cells/L vs 3.14 (1.48-15.7)×10 9 cells/L ( Figure S3A ). The number of granulocytes decreased: 0.055 (0.03-0.08)×10 9 cells/L vs 0.22 (0.04-0.69)×10 9 cells/L ( Figure S3B )."
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